Showing 661 - 680 results of 737 for search '"cancer immunology"', query time: 0.18s Refine Results
  1. 661
  2. 662
  3. 663
  4. 664
  5. 665
  6. 666
  7. 667
  8. 668
  9. 669
  10. 670
  11. 671
  12. 672
  13. 673

    Blocking LAIR1 signaling in immune cells inhibits tumor development by Jingjing Xie, Xun Gui, Mi Deng, Heyu Chen, Yuanzhi Chen, Xiaoye Liu, Zhiqiang Ku, Lingxiao Tan, Ryan Huang, Yubo He, Bruce Zhang, Cheryl Lewis, Kenian Chen, Kenian Chen, Lin Xu, Lin Xu, Jian Xu, Tao Huang, X. Charlene Liao, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang

    Published 2022-09-01
    “…New molecular targets and therapeutic approaches of cancer immunology need to be identified. Leukocyte associated immunoglobulin like receptor 1 (LAIR1) is an immune inhibitory receptor expressing on most immune cell types. …”
    Get full text
    Article
  14. 674
  15. 675
  16. 676
  17. 677

    CD24-Fc suppression of immune related adverse events in a therapeutic cancer vaccine model of murine neuroblastoma by Xiaofang Wu, Priya Srinivasan, Mousumi Basu, Talia Zimmerman, Samuel Li, Yin Wang, Pan Zheng, Yang Liu, Anthony David Sandler

    Published 2023-06-01
    “…The CD24-Siglec 10/G interaction is an innate checkpoint that abrogates inflammatory responses to molecules released by damaged cells, but its role in cancer immunology is not well defined. We investigate irAEs of an effective whole cell neuroblastoma vaccine and subsequently the effect of CD24-Fc, a CD24 and Fc fusion protein, on both the vaccine efficacy and induced irAEs in a mouse neuroblastoma model.MethodsTo test whether the whole tumor cell vaccination leads to autoimmune responses in other organ systems we harvested lung, heart, kidney and colon from naïve mice (n=3), unvaccinated tumor only mice (n=3), and vaccinated mice with CD24 Fc (n=12) or human IgG-Fc control (n=12) after tumor inoculation and vaccination therapy at day 30. …”
    Get full text
    Article
  18. 678
  19. 679
  20. 680